FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321071306> ?p ?o ?g. }

• W2321071306 endingPage "968" @default.
• W2321071306 startingPage "959" @default.
• W2321071306 abstract "Background Recent studies have indicated that interferon (IFN) or pegylated interferon (PEG-IFN) plus ribavirin therapy can achieve sustained virological response (SVR) against HCV equally in dual HBV–HCV infection and in HCV monoinfection. Whether these therapies can reduce hepatocellular carcinoma (HCC) development in dual HBV–HCV infection remains unclear. Methods A total of 135 dually-infected patients with active hepatitis C receiving IFN or PEG-IFN plus ribavirin therapy were enrolled. The cumulative incidence of HCC was compared to that in 1,470 HCV-monoinfected patients. Results Based on the Cox proportional hazards model, dual infection was an independent factor for HCC development in all 1,605 chronic hepatitis C patients with or without positive hepatitis B surface antigen receiving IFN or PEG-IFN plus ribavirin (hazard ratio (HR)=1.864, 95% CI 1.052–3.303; P=0.033). In dually-infected patients, HCC developed in 4 of 96 with HCV SVR and 11 of 39 without HCV SVR ( P<0.001) after a median follow-up of 4.6 years. Age (HR=1.175, 95% CI 1.070–1.291; P=0.001) and non-HCV-SVR (HR=7.874, 95% CI 2.375–26.32; P=0.001) were independent factors for HCC development. Subgroup analysis showed that HCC occurrence was lower in patients with HCV SVR and HBV DNA levels <2,000 IU/ml at the end of treatment or follow-up compared to those with HCV SVR and HBV DNA levels ≥2,000 IU/ml ( P=0.034) and those without HCV SVR ( P<0.001). Conclusions Sustained HCV clearance by IFN or PEG-IFN plus ribavirin therapy may significantly reduce HCC in HBV–HCV dually-infected patients, whereas persistence or reactivation of HBV decreases the benefit of HCV SVR." @default.
• W2321071306 created "2016-06-24" @default.
• W2321071306 creator A5008054592 @default.
• W2321071306 creator A5016683607 @default.
• W2321071306 creator A5040415788 @default.
• W2321071306 creator A5044475640 @default.
• W2321071306 creator A5048625267 @default.
• W2321071306 creator A5052834447 @default.
• W2321071306 creator A5059995303 @default.
• W2321071306 date "2011-10-01" @default.
• W2321071306 modified "2023-10-18" @default.
• W2321071306 title "Sustained HCV Clearance by Interferon-Based Therapy Reduces Hepatocellular Carcinoma in Hepatitis B and C Dually-Infected Patients" @default.
• W2321071306 cites W184425049 @default.
• W2321071306 cites W1965797994 @default.
• W2321071306 cites W1972807219 @default.
• W2321071306 cites W1985143492 @default.
• W2321071306 cites W1986492786 @default.
• W2321071306 cites W1989448136 @default.
• W2321071306 cites W1990466254 @default.
• W2321071306 cites W1996650624 @default.
• W2321071306 cites W1998859748 @default.
• W2321071306 cites W2001897672 @default.
• W2321071306 cites W2005863439 @default.
• W2321071306 cites W2015824057 @default.
• W2321071306 cites W2026988369 @default.
• W2321071306 cites W2039709676 @default.
• W2321071306 cites W2040463160 @default.
• W2321071306 cites W2046169642 @default.
• W2321071306 cites W2047235770 @default.
• W2321071306 cites W2056648239 @default.
• W2321071306 cites W2056827569 @default.
• W2321071306 cites W2063285149 @default.
• W2321071306 cites W2068392225 @default.
• W2321071306 cites W2068507347 @default.
• W2321071306 cites W2072449071 @default.
• W2321071306 cites W2075282196 @default.
• W2321071306 cites W2085767270 @default.
• W2321071306 cites W2087648288 @default.
• W2321071306 cites W2103116252 @default.
• W2321071306 cites W2104389844 @default.
• W2321071306 cites W2108456380 @default.
• W2321071306 cites W2117951288 @default.
• W2321071306 cites W2120128540 @default.
• W2321071306 cites W2136624411 @default.
• W2321071306 cites W2142676726 @default.
• W2321071306 cites W2148345648 @default.
• W2321071306 cites W2159954692 @default.
• W2321071306 cites W2160447604 @default.
• W2321071306 cites W2163486683 @default.
• W2321071306 cites W2164385547 @default.
• W2321071306 cites W2169631718 @default.
• W2321071306 cites W2262473304 @default.
• W2321071306 cites W2405124719 @default.
• W2321071306 cites W4237472114 @default.
• W2321071306 cites W4327849090 @default.
• W2321071306 doi "https://doi.org/10.3851/imp1842" @default.
• W2321071306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22024511" @default.
• W2321071306 hasPublicationYear "2011" @default.
• W2321071306 type Work @default.
• W2321071306 sameAs 2321071306 @default.
• W2321071306 citedByCount "23" @default.
• W2321071306 countsByYear W23210713062012 @default.
• W2321071306 countsByYear W23210713062013 @default.
• W2321071306 countsByYear W23210713062014 @default.
• W2321071306 countsByYear W23210713062015 @default.
• W2321071306 countsByYear W23210713062016 @default.
• W2321071306 countsByYear W23210713062017 @default.
• W2321071306 countsByYear W23210713062018 @default.
• W2321071306 countsByYear W23210713062020 @default.
• W2321071306 countsByYear W23210713062021 @default.
• W2321071306 crossrefType "journal-article" @default.
• W2321071306 hasAuthorship W2321071306A5008054592 @default.
• W2321071306 hasAuthorship W2321071306A5016683607 @default.
• W2321071306 hasAuthorship W2321071306A5040415788 @default.
• W2321071306 hasAuthorship W2321071306A5044475640 @default.
• W2321071306 hasAuthorship W2321071306A5048625267 @default.
• W2321071306 hasAuthorship W2321071306A5052834447 @default.
• W2321071306 hasAuthorship W2321071306A5059995303 @default.
• W2321071306 hasBestOaLocation W23210713061 @default.
• W2321071306 hasConcept C126322002 @default.
• W2321071306 hasConcept C203014093 @default.
• W2321071306 hasConcept C207103383 @default.
• W2321071306 hasConcept C2522874641 @default.
• W2321071306 hasConcept C2776178377 @default.
• W2321071306 hasConcept C2776408679 @default.
• W2321071306 hasConcept C2776455275 @default.
• W2321071306 hasConcept C2776461080 @default.
• W2321071306 hasConcept C2776999253 @default.
• W2321071306 hasConcept C2778019345 @default.
• W2321071306 hasConcept C2780040827 @default.
• W2321071306 hasConcept C2780593183 @default.
• W2321071306 hasConcept C44249647 @default.
• W2321071306 hasConcept C71924100 @default.
• W2321071306 hasConcept C72563966 @default.
• W2321071306 hasConcept C88879693 @default.
• W2321071306 hasConcept C90924648 @default.
• W2321071306 hasConceptScore W2321071306C126322002 @default.
• W2321071306 hasConceptScore W2321071306C203014093 @default.

• next